We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IQVIA (IQV) Q4 Earnings and Revenues Beat Mark, Rise Y/Y
Read MoreHide Full Article
IQVIA Holdings Inc. (IQV - Free Report) reported solid fourth-quarter 2022 results, wherein both earnings and revenues surpassed the respective Zacks Consensus Estimate.
Adjusted earnings per share (excluding $1.58 from non-recurring items) of $2.78 beat the Zacks Consensus Estimate by 1.1% and improved 9% on a year-over-year basis. The reported figure was within the guided range of $2.72-$2.82 per share.
Total revenues of $3.74 billion outpaced the Zacks Consensus Estimate by 0.9% and increased 2.8% year over year on a reported basis and 7% on a constant-currency basis. The reported figure fell within the guided range of $3.654-$3.754 billion.
Segmental Revenues
Revenues from Technology & Analytics Solutions totaled $1.5 billion, up 0.2% on a reported basis and 4.7% on a constant-currency basis.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
Research & Development Solutions’ revenues of $2.1 billion increased 5.9% on a reported basis and 9.3% on a constant-currency basis.
Revenues from Contract Sales & Medical Solutions totaled $182 million, down 7.1% on a reported basis but up 2% on a constant-currency basis.
Operating Performance
Adjusted EBITDA was $920 million, up 11.1% year over year.
Balance Sheet and Cash Flow
IQVIA exited fourth-quarter 2022 with cash and cash equivalents of $1.22 billion compared with $1.27 billion at the end of the prior quarter. Long-term debt (less current portion) was $12.6 billion compared with $12.24 billion at the end of the prior quarter.
IQV generated $560 million of cash from operating activities in the reported quarter, while CapEx was $171 million. Free cash flow was $389 million.
The company repurchased shares worth $25 million in fourth-quarter 2022. As of Dec 31, 2022, IQVIA had $1.35 million of its share buyback authorization outstanding.
2023 Guidance
IQVIA now expects revenues between $15.15 billion and $15.40 billion (representing growth of 5.1-6.9% on a reported basis and 5-6.8% at constant currency). The current Zacks Consensus Estimate of $14.38 billion lies below the updated guidance.
Adjusted earnings per share are expected between $10.26 and $10.56 (up 1-3.9%). The current Zacks Consensus Estimate is pegged at $10.14, lies below the updated guidance.
Adjusted EBITDA is anticipated between $3.625 billion and $3.695 billion.
Robert Half International Inc. (RHI - Free Report) reported mixed fourth-quarter 2022 results, wherein earnings beat the Zacks Consensus Estimate but revenues missed.
Quarterly earnings of $1.37 per share beat the Zacks Consensus Estimate by 1.5% but declined 9.3% year over year. Revenues of $1.73 billion missed the Zacks Consensus Estimate by 0.6% and decreased 2.4% year over year.
Automatic Data Processing, Inc. (ADP - Free Report) reported better-than-expected second-quarter fiscal 2023 results.
Adjusted earnings per share of $1.96 beat the Zacks Consensus Estimate by 0.5% and grew 19% from the year-ago fiscal quarter’s reading. Total revenues of $4.4 billion beat the Zacks Consensus Estimate by 0.3% and improved 9.1% from the year-ago fiscal quarter’s reading on a reported basis and 10% on an organic constant-currency basis.
Booz Allen Hamilton Holding Corp. (BAH - Free Report) reported impressive third-quarter fiscal 2023 results, with both earnings and revenues beating the respective Zacks Consensus Estimate. Quarterly adjusted earnings (excluding 84 cents from non-recurring items) per share of $1.07 beat the Zacks Consensus Estimate by 4.9% and increased 4.9% on a year-over-year basis.
Total revenues of $2.3 billion beat the Zacks Consensus Estimate by 4% and increased 12.1% on a year-over-year basis.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IQVIA (IQV) Q4 Earnings and Revenues Beat Mark, Rise Y/Y
IQVIA Holdings Inc. (IQV - Free Report) reported solid fourth-quarter 2022 results, wherein both earnings and revenues surpassed the respective Zacks Consensus Estimate.
Adjusted earnings per share (excluding $1.58 from non-recurring items) of $2.78 beat the Zacks Consensus Estimate by 1.1% and improved 9% on a year-over-year basis. The reported figure was within the guided range of $2.72-$2.82 per share.
Total revenues of $3.74 billion outpaced the Zacks Consensus Estimate by 0.9% and increased 2.8% year over year on a reported basis and 7% on a constant-currency basis. The reported figure fell within the guided range of $3.654-$3.754 billion.
Segmental Revenues
Revenues from Technology & Analytics Solutions totaled $1.5 billion, up 0.2% on a reported basis and 4.7% on a constant-currency basis.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote
Research & Development Solutions’ revenues of $2.1 billion increased 5.9% on a reported basis and 9.3% on a constant-currency basis.
Revenues from Contract Sales & Medical Solutions totaled $182 million, down 7.1% on a reported basis but up 2% on a constant-currency basis.
Operating Performance
Adjusted EBITDA was $920 million, up 11.1% year over year.
Balance Sheet and Cash Flow
IQVIA exited fourth-quarter 2022 with cash and cash equivalents of $1.22 billion compared with $1.27 billion at the end of the prior quarter. Long-term debt (less current portion) was $12.6 billion compared with $12.24 billion at the end of the prior quarter.
IQV generated $560 million of cash from operating activities in the reported quarter, while CapEx was $171 million. Free cash flow was $389 million.
The company repurchased shares worth $25 million in fourth-quarter 2022. As of Dec 31, 2022, IQVIA had $1.35 million of its share buyback authorization outstanding.
2023 Guidance
IQVIA now expects revenues between $15.15 billion and $15.40 billion (representing growth of 5.1-6.9% on a reported basis and 5-6.8% at constant currency). The current Zacks Consensus Estimate of $14.38 billion lies below the updated guidance.
Adjusted earnings per share are expected between $10.26 and $10.56 (up 1-3.9%). The current Zacks Consensus Estimate is pegged at $10.14, lies below the updated guidance.
Adjusted EBITDA is anticipated between $3.625 billion and $3.695 billion.
Currently, IQVIA carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshots
Robert Half International Inc. (RHI - Free Report) reported mixed fourth-quarter 2022 results, wherein earnings beat the Zacks Consensus Estimate but revenues missed.
Quarterly earnings of $1.37 per share beat the Zacks Consensus Estimate by 1.5% but declined 9.3% year over year. Revenues of $1.73 billion missed the Zacks Consensus Estimate by 0.6% and decreased 2.4% year over year.
Automatic Data Processing, Inc. (ADP - Free Report) reported better-than-expected second-quarter fiscal 2023 results.
Adjusted earnings per share of $1.96 beat the Zacks Consensus Estimate by 0.5% and grew 19% from the year-ago fiscal quarter’s reading. Total revenues of $4.4 billion beat the Zacks Consensus Estimate by 0.3% and improved 9.1% from the year-ago fiscal quarter’s reading on a reported basis and 10% on an organic constant-currency basis.
Booz Allen Hamilton Holding Corp. (BAH - Free Report) reported impressive third-quarter fiscal 2023 results, with both earnings and revenues beating the respective Zacks Consensus Estimate. Quarterly adjusted earnings (excluding 84 cents from non-recurring items) per share of $1.07 beat the Zacks Consensus Estimate by 4.9% and increased 4.9% on a year-over-year basis.
Total revenues of $2.3 billion beat the Zacks Consensus Estimate by 4% and increased 12.1% on a year-over-year basis.